Helping shape the landscape since 1954Helping shape the landscape since 1954
Elanco Technology AcquisitionsCompany Background
Elanco has world-class resources and a strong track record of bringing innovation to the global market. Core competencies include: research and product development, manufacturing, regulatory expertise, marketing and a top-flight sales force. The Preferred Partner for Animal Health InnovationsElanco Animal Health is committed to being the preferred partner for delivering innovative solutions to the veterinary market. Elanco is strongly committed to building partnerships based on mutual trust, respect, and integrity. We recognize both partners possess valuable assets, and both have a mutual desire to optimize the market value of those assets. Seeking Innovative Molecules and TechnologiesElanco is currently seeking innovative molecules and technologies which can be developed into successful products. We are particularly interested in agents to control infectious diseases or enhance the production efficiency of food-producing animals (cattle, swine, and poultry) and therapeutic agents for managing acute and chronic diseases in companion animals (dogs and cats). We are also interested in technologies and molecules to control the internal and external parasites that adversely affect both groups of animals. Rapid Quality DecisionsWhen you contact Elanco, we will thoroughly evaluate the opportunity for alignment with Elanco’s interests and provide rapid quality decisions. Our evaluation includes careful examination of the technology by a dedicated team of experienced scientists focused on specific therapeutic areas. We will also perform an analysis of the potential market value and review the intellectual property landscape. Contact Elanco Technology AcquisitionsIf you have an innovative technology or molecule with application in veterinary medicine, Elanco would like to hear from you. Please limit your initial disclosure to non-confidential information and data. If there is mutual interest in the opportunity, we may enter into a confidentiality agreement to allow for further discussion and disclosure. We invite you to provide the information requested below for an evaluation of the opportunity.
You may submit your innovation to Elanco by email, mail or through the use of our online form.
|
Elanco Animal Health is a division of Eli Lilly and Company, a recognized leader in the human pharmaceutical arena since 1876. Elanco is a global research-based company with over 2000 employees dedicated to developing products to improve the health of animals which we market in more than 100 countries.